Clinical Trial Update: A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

View source ↗

Summary

Completed clinical trial survey examining experiences of patients with metastatic breast cancer receiving oral ibandronate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ibandronate (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer | Status: COMPLETED